Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$100,605
-$771,994 QoQ
Shares Held
10,680
-89.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#160
of 263 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. NVAX ranks #171 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,605 | 10,680 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $872,599 | 100,646 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $688,179 | 109,235 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $700,195 | 109,235 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $743,241 | 92,443 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,227,154 | 97,162 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $307,232 | 24,268 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $114,704 | 23,997 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $113,539 | 23,654 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $172,578 | 23,837 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $175,257 | 23,588 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,897,183 | 184,551 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,387,911 | 186,149 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,131,564 | 235,885 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $17,500,122 | 237,612 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $87,055,803 | 608,484 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $222,349,924 | 1,072,548 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $233,469,238 | 1,099,662 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $236,683,884 | 1,305,410 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $142,542,004 | 1,278,289 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $243,535,152 | 2,247,671 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $251,418,939 | 3,016,424 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $23,439,419 | 1,726,025 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||